Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”

In the article titled “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab” [1], there were errors, which should be corrected as follows:

1. In Abstract, the term “(DEP)” should be “(PED).”

2. In Results, “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 91 µm, NS; M12: 312 ± 84 µm, NS; M24: 312 ± 12.3, NS)” should be corrected to “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 14 µm, NS; M12: 313 ± 13.9 µm, NS; M24: 305 ± 76, NS).”

3. In Table 2, there were errors in the values in the third, fourth, and sixth columns. The corrected table and its description are shown below.

Table 2.

Comparison of functional and morphologic changes from time of switch to 24 months.

Central macular thickness (µm)	Baseline	Month 3	P	Month 6	P	Month 12	P	Month 24	P
	N=44	N=44		N=44		N=44		N=38
ETDRS	64.4 ± 13.1	67.6 ± 12.3	0.002	67.3 ± 11	0.005	64.8 ± 13	0.6	61.4 ± 13.8	0.2
Central macular thickness (µm)	313 ± 13	301 ± 77	0.2	312 ± 14.2	0.9	313 ± 13.9	0.9	305 ± 76	0.6
Macular volume (mm3)	7.70 ± 2.2	7.75 ± 0.16	0.8	7.8 ± 0.16	0.6	7.85 ± 0.16	0.4	7.8 ± 0.65	0.3
PED height (µm)	224.7 ± 18.5	198.5 ± 19.5	0.025	190 ± 17.3	0.05	224 ± 21	0.27	200 ± 19	0.14
Subfoveal choroidal thickness (µm)	179 ± 68					158 ± 67	0.2	174 ± 56	0.5

Data are mean  ±  SD unless indicated otherwise. P: continuous variables compared by independent samples t-test from baseline; ETDRS: Early Treatment Diabetic Retinopathy Score; PED: pigment epithelial detachment.